by Clinical Neuropsychologist Online | Sunday, July 28, 2024 | Dementia
Abstract INTRODUCTION Subjective cognitive decline (SCD) in amyloid-positive (Aβ+) individuals was proposed as a clinical indicator of Stage 2 in the Alzheimer’s disease (AD) continuum, but this requires further validation across cultures, measures, and...
by Clinical Neuropsychologist Online | Sunday, July 28, 2024 | Dementia
Abstract INTRODUCTION Older adults with multimorbidity are at high risk of cognitive impairment development. There is a lack of research on the associations between different multimorbidity measures and cognitive function among older Chinese adults living in the...
by Clinical Neuropsychologist Online | Sunday, July 28, 2024 | Dementia
Abstract INTRODUCTION Amid recent approvals, early Alzheimer’s disease (AD) remains an active area of treatment development. METHODS We performed a conjoint experiment to compare preferences among 26 patients with mild cognitive impairment for four trial...
by Clinical Neuropsychologist Online | Saturday, July 27, 2024 | Neuropsychology (general)
Volume 39, Issue 2, February 2025, Page 383-399. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: Aaron C. Lim Gali H. Weissberger Jenna Axelrod Laura...
by Clinical Neuropsychologist Online | Friday, July 26, 2024 | Neuropsychology (general)
Volume 39, Issue 2, February 2025, Page 324-346. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: Jeroen J. Roor Brechje Dandachi-FitzGerald Maarten J. V....
